William Kerr

11PUBLICATIONS
18CO-AUTHORS
Molecular targetsShip and platform structures (incl. maritime hydrodynamics)AllergyHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 07, 2026
SHIP1 is required for T cell surveillance of occult malignancies.

|Dec 23, 2023
Structure-Activity Studies on Bis-Sulfonamide SHIP1 Activators.

Shea T Meyer, Sandra Fernandes, Robert E Anderson

|Mar 07, 2023
Multistep IgE Mast Cell Desensitization Is a Dose- and Time-Dependent Process Partially Regulated by SHIP-1.

Ather Adnan, Shree Acharya, Leila A Alenazy

|Dec 11, 2022
N1-Benzyl Tryptamine Pan-SHIP1/2 Inhibitors: Synthesis and Preliminary Biological Evaluation as Anti-Tumor Agents.

Sandra Fernandes, Shea T Meyer, Jigisha P Shah

|May 04, 2022
Synthetic studies on the indane SHIP1 agonist AQX-1125.

Otto M Dungan, Shawn Dormann, Sandra Fernandes

|Dec 15, 2019
Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival.

Simar Pal Singh, Marjolein J W de Bruijn, Catarina Velaso Gago da Graça

Pageof 2